Search research articles
Contact Us
Filters
Showing results (111-120 of 155) with videos related to
Page
of 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick, Theo Ruers, Daniela E Aust, et al.
European Urology
|
July 27, 2015
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin
Samantha Cambier, Richard J Sylvester, Laurence Collette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2011
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
BMJ Open
|
February 12, 2021
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
Katharina Beyer, Lisa Moris, Michael Lardas, et al.
The Lancet. Oncology
|
January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
The Lancet. Oncology
|
June 15, 2014
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Julien Taieb, Josep Tabernero, Enrico Mini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 27, 2015
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2012
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
Matthias Preusser, Frank Winkler, Laurence Collette, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 155) with videos related to
Sort By:
Page
of 16
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick, Theo Ruers, Daniela E Aust, et al.
European Urology
|
July 27, 2015
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin
Samantha Cambier, Richard J Sylvester, Laurence Collette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2011
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
BMJ Open
|
February 12, 2021
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
Katharina Beyer, Lisa Moris, Michael Lardas, et al.
The Lancet. Oncology
|
January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
The Lancet. Oncology
|
June 15, 2014
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Julien Taieb, Josep Tabernero, Enrico Mini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 27, 2015
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2012
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
Matthias Preusser, Frank Winkler, Laurence Collette, et al.
Page
of 16